Video

Corey Siegel, MD, on Positioning JAK Inhibitors in IBD Management

06/23/2010

In this video, Corey Siegel, MD, previews his talk on positioning Janus-kinase inhibitors and small molecules for treating inflammatory bowel disease, which he will be presenting at the Advances in Inflammatory Bowel Disease 2020 virtual regional meeting on June 27. Read the full transcript here.

Corey Siegel, MD, is section chief of gastroenterology and hepatology at Dartmouth-Hitchcock Medical Center in New Hampshire.

For more information about AIBD 2020 Regionals and to register for upcoming sessions, visit https://www.aibdregionals.com.

Related Content

Hepatitis C
Hepatitis C
Michael Banks, MD, on Relaxed Criteria for Medicaid Program Increases DAA Treatment Use in HCV
08/24/2018
Michael Banks, MD, talks about how 2016 Medicaid criteria has allowed for increased access to direct-acting antiviral therapies among patients with hepatitis C virus for whom the costs of the treatments...
08/24/2018
Gastroenterology
gd
Gastroenterology
Immunomodulator Monotherapy Should Still Be Used in Practice
08/16/2018
08/16/2018
diabetes risk
Josh Baker
diabetes risk
Joshua Baker, MD, on the Risk of Diabetes Among Patients with RA
05/14/2021
Dr Baker, from the University of Pennsylvania, discusses his recent research into the association of inflammation with the risk of diabetes among patients with rheumatoid arthritis.
05/14/2021
Gastroenterology
Gastroenterology
Clinical Pediatric Inflammatory Bowel Disease: The Year in Review 2016
08/06/2018
08/06/2018
Bipolar Disorder
Bipolar Disorder
Charles Raison, MD, on Examining the Long-Term Use of Antidepressants
03/08/2021
Psych Congress Steering Committee member Charles Raison, MD, recently spoke with The Sun magazine about depression, diagnosing the disorder, and treatments for it, including antidepressants, psychedelics,...
03/08/2021